Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoyuki Maekawa is active.

Publication


Featured researches published by Tomoyuki Maekawa.


EMBO Reports | 2011

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

Mei He; Hiroshi Kubo; Konosuke Morimoto; Naoya Fujino; Takaya Suzuki; Toru Takahasi; Mitsuhiro Yamada; Mutsuo Yamaya; Tomoyuki Maekawa; Yasuhiko Yamamoto; Hiroshi Yamamoto

Clearance of apoptotic cells is necessary for tissue development, homeostasis and resolution of inflammation. The uptake of apoptotic cells is initiated by an ‘eat‐me’ signal, such as phosphatidylserine, on the cell surface and phagocytes recognize the signal by using specific receptors. In this study, we show that the soluble form of the receptor for advanced glycation end products (RAGE) binds to phosphatidylserine as well as to the apoptotic thymocytes. RAGE‐deficient (Rage−/−) alveolar macrophages showed impaired phagocytosis of apoptotic thymocytes and defective clearance of apoptotic neutrophils in Rage−/− mice. Our results indicate that RAGE functions as a phosphatidylserine receptor and assists in the clearance of apoptotic cells.


Immunogenetics | 2012

Positive selection of Toll-like receptor 2 polymorphisms in two closely related old world monkey species, rhesus and Japanese macaques.

Akiko Takaki; Akiko Yamazaki; Tomoyuki Maekawa; Hiroki Shibata; Kenji Hirayama; Akinori Kimura; Hirohisa Hirai; Michio Yasunami

Toll-like receptor 2 (TLR2) plays an important role in the recognition of a variety of pathogenic microbes. In the present study, we compared polymorphisms of TLR2 locus in two closely related old world monkey species, rhesus monkey (Macaca mulatta) and Japanese monkey (Macaca fuscata). By nucleotide sequencing of the third exon of TLR2 gene from 21 to 35 respective individuals, we could assign 17 haplotype combinations of 17 coding SNPs of ten non-synonymous and seven synonymous substitutions. A non-synonymous substitution at codon position 326 appeared to be differentially fixed in each species, asparagine for M. mulatta whereas tyrosine for M. fuscata, and may contribute to certain functional properties because it locates in the region contributing to ligand binding and interaction with dimerization partner of TLR2-TLR1 heterodimeric complex. Although TLR2 alleles have diverged to similar extent in both species, they have evolved in significantly different ways; TLR2 of M. fuscata has undergone purifying selection while the membrane-proximal part of the extracellular domain of M. mulatta TLR2 exhibits higher rates of non-synonymous substitutions, indicating a trace of Darwinian positive selection.


AIDS | 2014

HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low.

Masahiko Mori; Nuanjun Wichukchinda; Reiko Miyahara; Archawin Rojanawiwat; Panita Pathipvanich; Tomoyuki Maekawa; Toshiyuki Miura; Philip J. R. Goulder; Michio Yasunami; Koya Ariyoshi; Pathom Sawanpanyalert

Objective:To identify protective human leukocyte antigen (HLA) alleles in an HIV-infected south-east Asian population, in whom HLA-B*57 prevalence is lower than other ethnic groups, and HIV-1 CRF01_AE is the dominant circulating subtype. Design:Cross-sectional study of Thai patients with chronic HIV infection. Methods:Five hundred and fifty-seven HIV-1 CRF01_AE-infected Thais were recruited. Their HLA type and viral load were determined to statistically analyze the association of each allele in viral control. In-silico molecular dynamics was also used to evaluate the effect of HLA structure variants on epitope binding. Results:HLA-B*35:05 was identified as the most protective allele (P = 0.003, q = 0.17), along with HLA-B*57:01 (P = 0.044, q = 0.31). Structurally, HLA-B*35:05 belonged to the HLA-B*35-PY group of HLA-B*35 alleles; however, unlike the other HLA-B*35 alleles that carry Arg (R) at residue 97, it has unique sequences at T94, L95, and S97, located within the peptide-binding groove. Analysis of the three-dimensional HLA structure and molecular dynamics indicates that S97 in HLA-B*35:05 leads to less flexibility in the groove, and shorter distances between the &agr;-helixes compared with the disease-susceptible HLA-B*35-PY allele, HLA-B*35:01. Conclusion:These data indicate the existence of a protective effect of HLA-B*57 across ethnic groups and highlight HLA-B*35:05 as an allele uniquely protective in subtype CRF01_AE-infected Thais. The divergence of HLA-B*35:05 from conventional HLA-B*35-PY structural sequences at the peptide-binding groove is consistent with previous studies that have identified HLA residue 97 as strongly influential in shaping HLA impact on immune control of HIV, and that a more restricted peptide-binding motif may be associated with improved control.


PLOS ONE | 2012

Development of a Novel In Silico Docking Simulation Model for the Fine HIV-1 Cytotoxic T Lymphocyte Epitope Mapping

Masahiko Mori; Kei Matsuki; Tomoyuki Maekawa; Mari Tanaka; Busarawan Sriwanthana; Masaru Yokoyama; Koya Ariyoshi

Introduction Class I HLAs polymorphism has hampered CTL epitope mapping with laborious experiments. Objectives are 1) to evaluate the novel in silico model in predicting previously reported epitopes in comparison with existing program, and 2) to apply the model to predict optimal epitopes with HLA using experimental results. Materials and Methods We have developed a novel in silico epitope prediction method, based on HLA crystal structure and a peptide docking simulation model, calculating the peptide-HLA binding affinity at four amino acid residues in each terminal. It was applied to predict 52 HIV best–defined CTL epitopes from 15-mer overlapping peptides, and its predictive ability was compared with the HLA binding motif-based program of HLArestrictor. It was then used to predict HIV-1 Gag optimal epitopes from previous ELISpot results. Results 43/52 (82.7%) epitopes were detected by the novel model, whereas 37 (71.2%) by HLArestrictor. We also found a significant reduction in epitope detection rates for longer epitopes in HLArestrictor (p = 0.027), but not in the novel model. Improved epitope prediction was also found by introducing both models, especially in specificity (p<0.001). Eight peptides were predicted as novel, immunodominant epitopes in both models. Discussion This novel model can predict optimal CTL epitopes, which were not detected by an existing program. This model is potentially useful not only for narrowing down optimal epitopes, but predicting rare HLA alleles with less information. By introducing different principal models, epitope prediction will be more precise.


Biological Chemistry | 1978

The amino acid compositions of the tryptic, chymotryptic and peptic peptides from the L-2 light chain of rabbit skeletal muscle myosin.

Genji Matsuda; Yoji Suzuyama; Masayuki Setoguchi; Tetsuo Maita; Bunji Watanabe; Tomoyuki Maekawa; Toshiyo Umegane

The light chain fraction was separated from rabbit skeletal muscle myosin and four kinds of light chains, L-1, L-2, L-3 and L-4 in the fraction were further isolated by column chromatography using DEAE-cellulose DE-52. After amino-ethylation, the L-2 light chain was digested with trypsin. It was also digested with chymotrypsin and pepsin, respectively, after carboxymethylation. Each of the tryptic, chymotryptic and peptic peptides thus obtained was separated and purified and their amino acid compositions were analyzed.


Nippon Eiyo Shokuryo Gakkaishi | 1962

On the Effect of Excessive Supplement of Methionine on Albino Rats (1st Report)

Genji Matsuda; Chisato Hiwaki; Kazuko Oka; Tomoyuki Maekawa; Shinichi Kobayashi; Isamu Tachikawa; Harumasa Yoshida

In order to study the lipotropic and toxic actions of DL-methionine, rats of SD strain were divided into 3 groups and were maintained for 22 days on diets prepared by adding 10%, 5% or 0% DL-methionine respectively to a basal diet containing 10% casein and 30% fat. The effect of supplement on weight change, crude fat contents of the liver, and histopathologic changes in livers and kidneys were investigated.The rats in the 10% group showed a rapid weight decrease, and died successively after the 4th day. Those in the 5% group also showed a weight decrease, but were alive throughout the period of the experiment.In both 10% and 5% groups, the crude fat contents were equal with those of the normal groups, but the liver and kiney exhibited a remarkable fatty degeneration by the probable intoxication.


International Journal of Protein Research | 2009

HEMOGLOBIN NAGASAKI (αA/2 β17/2Glu) A NEW ABNORMAL HUMAN HEMOGLOBIN FOUND IN ONE FAMILY IN NAGASAKI

Masayuki Maekawa; Tomoyuki Maekawa; Naoko Fujiwara; Kunio Tabara; Genji Matsuda


Journal of Biochemistry | 1963

The Occurrence of β-Hydroxyasparagine in Normal Human Urine*

Fumio Tominaga; Chisato Hiwaki; Tomoyuki Maekawa; Harumasa Yoshida


International Journal of Protein Research | 2009

HEMOGLOBIN ATAGO (α852 Tyr β2) A NEW ABNORMAL HUMAN HEMOGLOBIN FOUND IN NAGASAKI

Naoko Fujiwara; Tomoyuki Maekawa; Genji Matsuda


Biological Chemistry | 1963

Die UV-Absorptionsspektren der α-, β- und γ-Polypeptidketten von den menschlichen Hämoglobinen

Genji Matsuda; Tomoyuki Maekawa; Ikuo Muta

Collaboration


Dive into the Tomoyuki Maekawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge